Nimesulide

CAS No. 51803-78-2

Nimesulide ( R805 )

Catalog No. M14806 CAS No. 51803-78-2

Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 27 In Stock
50MG 34 In Stock
100MG 45 In Stock
200MG 54 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nimesulide
  • Note
    Research use only, not for human use.
  • Brief Description
    Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties.
  • Description
    Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.
  • Synonyms
    R805
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    51803-78-2
  • Formula Weight
    308.31
  • Molecular Formula
    C13H12N2O5S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 62 mg/mL (201.09 mM)
  • SMILES
    CS(=O)(NC1=CC=C([N+]([O-])=O)C=C1OC2=CC=CC=C2)=O
  • Chemical Name
    N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rainsford KD. Curr Med Res Opin. 2006 Jun;22(6):1161-70.
molnova catalog
related products
  • ASP-6537

    ASP-6537 (ASP6537) is a novel potent, selective, reversible cyclooxygenase-1 (COX-1) inhibitor with IC50 of 4.9 nM.

  • Seratrodast

    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.

  • Sulfasalazine

    Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.